Genomind Blog

Search blog

    The Genomind Mental Health Poll™ 2017: What It Means for Patients

    on October 05, 2017

    Patients dealing with a mental health issue and advocates in the space can take pride in knowing their efforts to educate Americans are yielding some success. That’s one of the takeaways from this year’s annual Genomind Mental Health Poll.

    Read More

    Representative Brendan Boyle Tours the Genomind Lab

    on July 20, 2016

    Genomind was excited to highlight the importance of the biotech industry to Pennsylvania today when Representative Brendan Boyle, who represents Pennsylvania’s 13th Congressional District, visited our CLIA certified laboratory in King of Prussia, PA. This facility is where we perform our genetic testing that can help guide clinicians as to which mental health treatments are likely to work as intended, have no effect or cause adverse effects.

    Read More

    Pharmacogenetic Testing: A Look Inside the Life of a Patient Sample in the Genomind Lab

    on July 19, 2016

    We are at a truly unique point in medical history – doctors and patients now have more information and data available to them, creating a greater understanding of the human body than ever before. One groundbreaking evolution that has arisen is “pharmacogenetic testing,” which combines clinicians’ pharmacology knowledge with the study of how genes affect a person’s response to drugs.

    Read More

    The Importance of Genetic Testing And Why I Cofounded Genomind

    on May 09, 2016

    In recognition of Mental Health Awareness Month, one of our co-founders, Dr. Jay Lombard, explored the reason for creating Genomind and the future of genetic testing.

    Read More

    Search blog

      New call-to-action

      Popular Posts


      See all